Annual Microbiome Movement Summit 2026
A Boston summit focused on translating microbiome research into clinically validated therapies.
The Colonnade Hotel, Boston, MA
- Date
- November 9, 2026
- Venue
- The Colonnade Hotel, Boston, MA
TL;DR
- The 2026 summit starts November 9 at The Colonnade Hotel in Boston.
- Its focus is the development of microbiome-based therapies with clinical validation and commercial potential.
- The published audience includes senior biopharma leaders, regulators, and investors new to the microbiome field.
Who you'll find in the room
C-suite executives
Senior executives are part of the stated audience.
Vice presidents
Vice presidents are included in the stated audience.
Director-level leaders
Directors are among the audience roles identified by the organizer.
Biopharma professionals
The audience includes leaders from biopharma companies.
Regulators
Regulatory professionals are included in the audience description.
Microbiome-curious attendees
The organizer also identifies people exploring the microbiome field.
First-time investors
Investors new to the field are part of the stated audience.
Featured speakers
10 listedBernat Olle
Chief Executive Officer · Vedanta Biosciences
Todd Krueger
Chief Executive Officer · AOBiome
Katja Conrath
Chief Scientific Officer · MRM Health
Philip Burnham
Chief Scientific Officer · Kanvas Biosciences
Ken Blount
Senior Vice President, Head of Microbiome Clinical & Product Development · Ferring Pharmaceuticals
Jason Goldsmith
Senior Director, Microbiome Sciences · Nestle Health Science
Eddie Moradian
Chief Executive Officer · Salspera
Alexander Khoruts
Chief Medical Officer · Gut-Brain Axis Therapeutics
Bharat Dixit
Chief Technology Officer · Adiso Therapeutics
Vanessa Ridaura
Senior Program Officer - Microbiome Products · The Gates Foundation
Partners on record
6 listedVenue & travel
Venue
The Colonnade HotelQuestions people ask
5 answeredThe summit starts on November 9, 2026.
The 2026 summit is at The Colonnade Hotel in Boston, Massachusetts.
The stated audience spans senior biopharma leaders, regulators, people exploring the microbiome field, and first-time investors.
Academic researchers, early-career scientists and consumer probiotic marketers will get less from it, because the focus is clinical validation and commercial viability of therapies for pharma and investor audiences.
Biopharma partnering conferences usually call for business casual, such as slacks and a blazer or sweater, and suits are less common than at finance events; Boston in November also calls for a warm coat.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in